AlphaQuest LLC reduced its position in Colgate-Palmolive Company (NYSE:CL – Free Report) by 45.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 2,816 shares of the company’s stock after selling 2,334 shares during the period. AlphaQuest LLC’s holdings in Colgate-Palmolive were worth $256,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in CL. Personal CFO Solutions LLC acquired a new position in Colgate-Palmolive during the first quarter worth $285,000. Vision Capital Management Inc. purchased a new position in shares of Colgate-Palmolive in the first quarter valued at $322,000. Financial Gravity Asset Management Inc. acquired a new position in shares of Colgate-Palmolive during the 1st quarter worth $2,166,000. Cidel Asset Management Inc. boosted its position in shares of Colgate-Palmolive by 13.6% in the 2nd quarter. Cidel Asset Management Inc. now owns 329,060 shares of the company’s stock worth $29,912,000 after buying an additional 39,413 shares in the last quarter. Finally, Penserra Capital Management LLC grew its stake in Colgate-Palmolive by 398.6% in the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock valued at $997,000 after acquiring an additional 8,515 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently commented on CL. UBS Group lowered their price target on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Raymond James Financial lowered their target price on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a research report on Friday, October 10th. Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Finally, The Goldman Sachs Group dropped their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, October 2nd. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $91.50.
Colgate-Palmolive Trading Up 0.8%
Shares of CL stock opened at $77.10 on Friday. The firm’s 50-day simple moving average is $80.45 and its 200-day simple moving average is $86.33. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a 1-year low of $74.62 and a 1-year high of $100.18. The firm has a market cap of $62.32 billion, a P/E ratio of 21.66, a PEG ratio of 4.44 and a beta of 0.34.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive’s revenue was up 1.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 earnings per share. As a group, equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Comparing and Trading High PE Ratio Stocks
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- How to Buy Cheap Stocks Step by Step
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
